{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T03:12:20Z","timestamp":1769310740137,"version":"3.49.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"48","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,6,3]],"date-time":"2018-06-03T00:00:00Z","timestamp":1527984000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1175118"],"award-info":[{"award-number":["OPP1175118"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.vaccine.2018.05.035","type":"journal-article","created":{"date-parts":[[2018,5,19]],"date-time":"2018-05-19T07:50:43Z","timestamp":1526716243000},"page":"7430-7437","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Vaccines, inspiring innovation in health"],"prefix":"10.1016","volume":"36","author":[{"given":"Sonia","family":"Pagliusi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maureen","family":"Dennehy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.05.035_b0005","unstructured":"Kwon DC. Inaugral address: DCVMN Annual General Meeting. 2017. <http:\/\/www.dcvmn.org\/2017-Annual-Meeting-in-Seoul>."},{"key":"10.1016\/j.vaccine.2018.05.035_b0010","unstructured":"Gavi. Annual progress report. 2016:65. <http:\/\/www.gavi.org\/results\/gavi-progress-reports\/>."},{"key":"10.1016\/j.vaccine.2018.05.035_b0015","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1377\/hlthaff.2011.0382","article-title":"Estimated economic benefits during the \u201c Decade Of Vaccines\u201d include treatment savings, gains in labor productivity","volume":"30","author":"Stack","year":"2011","journal-title":"Health Aff"},{"key":"10.1016\/j.vaccine.2018.05.035_b0020","doi-asserted-by":"crossref","first-page":"B61","DOI":"10.1016\/j.vaccine.2012.11.035","article-title":"The estimated mortality impact of vaccinations forecast to be administered during 2011\u20132020 in 73 countries supported by the GAVI Alliance","volume":"315","author":"Lee","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.05.035_b0025","unstructured":"WHO. Progress and challenges with achieving universal immunization coverage: 2016 estimates of immunization coverage. 2017. <http:\/\/www.who.int\/immunization\/monitoring_surveillance\/who-immuniz.pdf>."},{"key":"10.1016\/j.vaccine.2018.05.035_b0030","unstructured":"SAGE. Assessment report of the Global Vaccine Action Plan. 2017:30. <http:\/\/www.who.int\/immunization\/sage\/meetings\/2017\/october\/1_GVAP_Assessment_report_web_version.pdf>."},{"key":"10.1016\/j.vaccine.2018.05.035_b0035","unstructured":"WHO. V3P price database. <http:\/\/www.who.int\/immunization\/programmes_systems\/procurement\/v3p\/platform\/module1\/en\/>; 2017 [accessed November 15, 2017]."},{"key":"10.1016\/j.vaccine.2018.05.035_b0040","unstructured":"UNICEF. Supply Annual Report. 2017:103. <https:\/\/www.unicef.org\/supply\/files\/Supply_Annual_Report_2016.pdf>."},{"key":"10.1016\/j.vaccine.2018.05.035_b0045","unstructured":"Gavi. Supply and procurement roadmaps. <http:\/\/www.gavi.org\/about\/market-shaping\/supply-and-procurement-roadmaps\/>; 2017 [accessed November 20, 2017]."},{"key":"10.1016\/j.vaccine.2018.05.035_b0050","unstructured":"MSF. The right shot: bringing down barriers to affordable and adapted vaccines. 2015. file:\/\/\/C:\/Users\/Em\/Desktop\/VAC_report_TheRightShot2ndEd_ENG_2015.pdf."},{"key":"10.1016\/j.vaccine.2018.05.035_b0055","unstructured":"MSF. A fair shot for vaccine affordability. Understanding and addressing the effects of patents on access to newer vaccines. 2017:37. <https:\/\/www.msfaccess.org\/sites\/default\/files\/VAC_report_A Fair Shot for Vaccine Affordability_ENG_2017.pdf>."},{"key":"10.1016\/j.vaccine.2018.05.035_b0060","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMoa1609462","article-title":"Efficacy of a low-cost, heat-stable oral rotavirus vaccine in Niger","volume":"376","author":"Isanaka","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2018.05.035_b0065","unstructured":"WHO. Joint external evaluation tool. International health regulations (2005). 2016:92. <http:\/\/apps.who.int\/iris\/bitstream\/10665\/204368\/1\/9789241510172_eng.pdf>."},{"key":"10.1016\/j.vaccine.2018.05.035_b0070","unstructured":"CEPI. Preliminary Business Plan 2017-2021. <lhttp:\/\/cepi.net\/sites\/default\/files\/CEPI Preliminary Business Plan 011116.pdf>; 2017 [accessed 15 November 2017]."},{"key":"10.1016\/j.vaccine.2018.05.035_b0075","unstructured":"WHO. Eliminate Yellow fever Epidemics (EYE): a global strategy, 2017-2026. Wkly Epidemiol Rec 2017;16:193\u2013204. <http:\/\/doi.org\/10.1371\/journal.pmed.1001638>."},{"key":"10.1016\/j.vaccine.2018.05.035_b0080","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/S0140-6736(16)30623-7","article-title":"MERS-CoV outbreak following a single patient exposure in an emergency room in South Korea: an epidemiological outbreak study","volume":"388","author":"Cho","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2018.05.035_b0085","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nrmicro.2016.81","article-title":"SARS and MERS: recent insights into emerging coronaviruses","volume":"14","author":"de Wit","year":"2016","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2018.05.035_b0090","doi-asserted-by":"crossref","unstructured":"Muthumani K, Falzarano D, Reuschel EL, Tingey C, Flingai S, Villarreal DO, et al. A synthetic consensus anti\u2013spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates. Sci Transl Med 2015;7. <http:\/\/doi.org\/10.1126\/scitranslmed.aac7462>.","DOI":"10.1126\/scitranslmed.aac7462"},{"key":"10.1016\/j.vaccine.2018.05.035_b0095","unstructured":"WHO. Integrating neglected tropical diseases into global health and development. 4th ed. World Health Organization, Geneva; 2017."},{"key":"10.1016\/j.vaccine.2018.05.035_b0100","unstructured":"AVMI. Vaccine manufacturing and procurement in Africa. An analytical assessment of vaccine manufacturing capacity and procurement mechanisms for extablishing sustainable vaccine manufacturing capacity in Africa. African Vaccine Manufacturing Initiative, South Africa. Available at <http:\/\/www.avmi-africa.org\/projects\/current-projects\/>; 2017 [accessed 20 November 2017]."},{"key":"10.1016\/j.vaccine.2018.05.035_b0105","unstructured":"WHO. Emergency Use Assessment and Listing procedure (EUAL) for candidate vaccines for use in the context of a public health emergency. World Health Organization, Geneva; 2015."},{"key":"10.1016\/j.vaccine.2018.05.035_b0110","unstructured":"Dellepiane N, Pagliusi S, Vaccine Registration Experts\u2019 Group. Challenges for the registration of vaccines in emerging countries. n.d. Unpublished results."},{"key":"10.1016\/j.vaccine.2018.05.035_b0115","first-page":"127","article-title":"The African Vaccine Regulatory Forum (AVAREF): platform for collaboration in a public health emergency","volume":"29","author":"Akanmori","year":"2015","journal-title":"WHO Drug Inf"},{"key":"10.1016\/j.vaccine.2018.05.035_b0120","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.vaccine.2009.09.117","article-title":"Joint reviews and inspections: strategic forms of collaboration for strengthening the regulatory oversight of vaccine clinical trials in Africa","volume":"28","author":"Ma\u00efga","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.05.035_b0125","unstructured":"WHO. Assessing the programmatic suitability of vaccine candidates for WHO prequalification. WHO\/IVB\/14. World Health Organization, Geneva; 2014."},{"key":"10.1016\/j.vaccine.2018.05.035_b0130","unstructured":"WHO. Out of cold chain (OCC) and Controlled Temperature Chain (CTC) use of vaccines. Immunization Practices Advisory Committee, World Health Organization, Geneva; 2017."},{"key":"10.1016\/j.vaccine.2018.05.035_b0135","unstructured":"WHO. Strategic roadmap for priority vaccines. WHO\/IVB\/17. Immunization Practices Advisory Committee, World Health Organization, Geneva; 2017."},{"key":"10.1016\/j.vaccine.2018.05.035_b0140","unstructured":"WHO. PQS performance specification: Vaccine Vial Monitor. WHO\/PQS\/E0. World Health Organization, Geneva; 2006."},{"key":"10.1016\/j.vaccine.2018.05.035_b0145","unstructured":"WHO. Generic preferred product profile for vaccines. 2.1. Vaccine Presentation and Packaging Advisory Group, World Health Organization, Geneva, 2015."},{"key":"10.1016\/j.vaccine.2018.05.035_b0150","unstructured":"GS1. Healthcare reference book. Successful implementations of GS1 standards. 2015\u20132016. ed. GS1, Belgium; 2016."},{"key":"10.1016\/j.vaccine.2018.05.035_b0155","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1016\/j.vaccine.2013.08.037","article-title":"A novel method for purification of Vi capsular polysaccharide produced by Salmonella enterica subspecies enterica serovar Typhi","volume":"31","author":"Kothari","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.05.035_b0160","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0140-6736(11)61651-6","article-title":"Group B streptococcal disease in infants aged younger than 3 months : systematic review and meta-analysis","author":"Edmond","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2018.05.035_b0165","unstructured":"WHO. Group B Streptococcus vaccine development technology roadmap. Priority activities for development, testing, licensure and global availability of Group B streptococcys vaccines. WHO\/IVB\/17. World Health Organization, Geneva; 2017."},{"key":"10.1016\/j.vaccine.2018.05.035_b0170","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1016\/j.vaccine.2017.04.025","article-title":"Stability of heat stable, live attenuated Rotavirus vaccine (ROTASIIL\u00ae)","volume":"35","author":"Naik","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.05.035_b0175","doi-asserted-by":"crossref","first-page":"6360","DOI":"10.1016\/j.vaccine.2015.08.075","article-title":"A randomized, non-inferiority trial comparing two bivalent killed, whole cell, oral cholera vaccines (Euvichol vs Shanchol) in the Philippines","volume":"33","author":"Baik","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.05.035_b0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3201\/eid2105.141756","article-title":"Detecting Spread of Avian Influenza A (H7N9) Virus Beyond China","volume":"21","author":"Millman","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2018.05.035_b0185","doi-asserted-by":"crossref","first-page":"928","DOI":"10.15585\/mmwr.mm6635a2","article-title":"Update : increase in human infections with novel asian lineage avian influenza A (H7N9) viruses during the fifth epidemic - China, October 1, 2016 - August 7, 2017","volume":"66","author":"Kile","year":"2017","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2018.05.035_b0190","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1016\/j.vaccine.2017.06.044","article-title":"Safety and immunogenicity of an inactivated cell culture-derived H7N9 influenza vaccine in healthy adults : A phase I \/ II, prospective","volume":"35","author":"Wu","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.05.035_b0195","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1128\/CVI.00112-06","article-title":"Development and Validation of a Fourfold Multiplexed Opsonization Assay (MOPA4) for Pneumococcal Antibodies","volume":"13","author":"Burton","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2018.05.035_b0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CVI.00457-16","article-title":"Assignment of opsonic values to pneumococcal reference serum 007sp for use in opsonophagocytic assays for 13 serotypes","volume":"24","author":"Burton","year":"2017","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2018.05.035_b0205","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1016\/j.vaccine.2005.01.085","article-title":"Insufficient protection for healthy elderly adults by tetanus and TBE vaccines","volume":"23","author":"Hainz","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.05.035_b0210","doi-asserted-by":"crossref","first-page":"7446","DOI":"10.4049\/jimmunol.174.11.7446","article-title":"The influence of age on T cell generation and TCR diversity","volume":"174","author":"Naylor","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.05.035_b0215","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1056\/NEJMoa1209165","article-title":"Hospitalizations for pneumonia after a decade of pneumococcal vaccination","volume":"369","author":"Griffin","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2018.05.035_b0220","unstructured":"WHO. National immunization coverage scorecards. Estimates for 2016. World Health Organization, Geneva; 2017."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18306558?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18306558?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:29:20Z","timestamp":1759400960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18306558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":44,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0264410X18306558"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.05.035","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccines, inspiring innovation in health","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.05.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}